参考文献/References:
[1] 郭慧敏,孔为民.子宫内膜癌治疗后随访策略的研究进展[J].肿瘤学杂志,2022,28(7):533-538.
[2] KIEWISZ J,WASNIEWSKI T,KIEZUN J,et al.WNT4 gene and protein expression in endometrial cancer and its significance[J].Cancers(Basel),2023,15(19):4780.
[3] 李平,任斌,李洪利,等.miR-150-5p通过靶向调控Rab1A抑制乳腺癌细胞MDA-231的上皮-间质转化[J].中国生物化学与分子生物学报,2018,34(9):997-1003.
[4] 石少敏,赵建军,于杜鹃,等.miR-320a靶向Rab11a调控非小细胞肺癌细胞增殖的研究[J].中国实验诊断学,2018,22(9):1636-1638.
[5] LIU J,SHI Y,WU M,et al.JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1[J].Genes Dis,2022,10(5):2167-2178.
[6] ESPOSITO J E,DE IULIIS V,AVOLIO F,et al.Dissecting the functional role of the TRIM8 protein on cancer pathogenesis[J].Cancers(Basel),2022,14(9):2309.
[7] MARZANO F,CARATOZZOLO M F,PESOLE G,et al.TRIM proteins in colorectal cancer:TRIM8 as a promising therapeutic target in chemo resistance[J].Biomedicines,2021,9(3):241.
[8] 刘洋洋,盛誉乔,薛瑞,等.PARP抑制剂调节肿瘤免疫的研究进展[J].郑州大学学报(医学版),2023,58(1):62-67.
[9] 武宸宇,徐慧,张蓓.miR-182-5p、TRIM8在子宫内膜癌组织中的表达及其临床意义[J].徐州医学院学报,2021,41(12):893-899.
[10] 李美月,田文艳,闫晔,等.Rab35蛋白在子宫内膜癌中的表达及其临床意义[J].中国妇产科临床杂志,2019,0(4):351-353.
[11] 宫莹莹,何玉,席玉玲.PARP-1、Caspase-3在子宫内膜癌组织中的表达变化及意义[J].山东医药,2017,57(44):92-94.
[12] 都燕,代佳.血清细胞角蛋白19片段、α-烯醇化酶检测在子宫内膜癌诊断及病情严重程度评估中的价值[J].陕西医学杂志,2023,52(2):212-216.
[13] 贾丽.大蒜素对人子宫内膜癌Ishikawa细胞侵袭和迁移抑制作用的研究[J].陕西中医,2020,41(8):1042-1046.
[14] 高歌.黄芪注射液治疗子宫内膜肿瘤临床疗效及对患者肿瘤标志物血清CA125、HE4影响的研究[J].陕西中医,2018,39(6):762-765.
[15] 邵娟,白淑玮,田蕴霖.高迁移率族蛋白B-1和NADPH氧化酶衍生活性氧对糖尿病视网膜病变大鼠视网膜电图波幅和玻璃体通透性的影响[J].陕西医学杂志,2022,51(5):515-519,524.
[16] MICHALAK T I.The initial hepatitis B virus-hepatocyte genomic integrations and their role in hepatocellular oncogenesis[J].Int J Mol Sci,2023,24(19):14849.
[17] GIBIEZA P,PETRIKAITE V.The dual functions of Rab11 and Rab35 GTPases-regulation of cell division and promotion of tumorigenicity[J].Am J Cancer Res,2021,11(5):1861-1872.
[18] VILLAGOMEZ F R,MEDINA-CONTRERAS O,CERNA-CORTES J F,et al.The role of the oncogenic Rab35 in cancer invasion,metastasis,and immune evasion,especially in leukemia[J].Small GTPases,2020,11(5):334-345.
[19] MASTROPASQUA F,MARZANO F,VALLETTI A,et al.TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours[J].Mol Cancer,2017,16(1):67.
[20] CARATOZZOLO M F,MARZANO F,MASTROPASQUA F,et al.TRIM8:Making the right decision between the oncogene and tumour suppressor role[J].Genes(Basel),2017,8(12):354.
[21] 崔熙,张小玲,李旭,等.基于网络药理学鉴定人参皂苷Rg3抗卵巢癌的分子靶点研究[J].中国妇幼健康研究,2022,33(9):83-89.
[22] 曾靖,尹如铁.PARP抑制剂在子宫内膜癌治疗中的研究进展[J].实用妇产科杂志,2020,36(1):28-30.
[23] 何彩平,黄梅秀,林艳华,等.Rab35、TMPRSS4及CIP2A蛋白在子宫内膜癌中的表达及与预后的关系[J].保健医学研究与实践,2021,18(5):93-98.
[24] 贺英,刘晓娟,王静,等.MRI ADC直方图在子宫内膜癌诊断及肿瘤浸润评估中的应用[J].影像科学与光化学,2022,40(5):1093-1097.
[25] 许高云,夏步胜,蒋业忠.子宫内膜癌组织中血管内皮生长因子-C、细胞增殖抗原Ki-67的表达及意义[J].中国临床医生杂志,2022,50(4):481-484.
相似文献/References:
[1]冯苗苗,曹秋雨.miR335在子宫内膜癌患者血清中的表达及检测临床意义[J].陕西医学杂志,2019,(2):252.
FENG Miaomiao,CAO Qiuyu..The expression and significance of miR335 in serum of patients with endometrial carcinoma[J].,2019,(2):252.
[2]刘家利,谢小军.子宫内膜癌组织HIF-1α、血清CA125水平在患者病情与疾病预后评估中的价值[J].陕西医学杂志,2019,(6):800.
[3]张晓勇.宫腔镜辅助下分段诊刮术与单纯分段诊刮术诊断子宫内膜癌价值比较[J].陕西医学杂志,2019,(8):1045.
ZHANG Xiaoyong..Comparison of hysteroscopy assisted dilatation and curettage and traditional dilatation
and curettage in the diagnosis of endometrial carcinoma[J].,2019,(2):1045.
[4]徐 珊,程 珂,刘鹏宇.子宫内膜癌组织血管紧张素(1-7)、miR-106b表达与患者临床病理分期相关性研究[J].陕西医学杂志,2022,51(5):621.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.025]
XU Shan,Cheng Ke,LIU Pengyu.Correlation between the expression of angiotensin(1-7),miR-106b in endometrial cancer tissue and clinicopathological stage of patients[J].,2022,51(2):621.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.025]
[5]都 燕,代 佳.血清细胞角蛋白19片段、α-烯醇化酶检测在子宫内膜癌诊断及病情严重程度评估中的价值[J].陕西医学杂志,2023,52(2):212.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.022]
DU Yan,DAI Jia.Value of serum cytokeratin 19 fragment and α-enolase detection in diagnosis and severity assessment of endometrial carcinoma[J].,2023,52(2):212.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.022]
[6]姚 田,马文娟.RP11-444D3.1与SOX5基因共表达激活cofilin/LIMK/Rac信号通路介导子宫内膜癌侵袭机制研究[J].陕西医学杂志,2023,52(4):390.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.006]
YAO Tian,MA Wenjuan.Co-expression of RP11-444D3.1 and SOX5 enhances endometrial cancer invasion by activating cofilin/LIMK/Rac pathway[J].,2023,52(2):390.[doi:DOI:10.3969/j.issn.1000-7377.2023.04.006]
[7]查善辉,刘 杰,任 洁,等.腹腔镜手术治疗老年子宫内膜癌疗效及对患者应激、疼痛和术后恢复的影响[J].陕西医学杂志,2023,52(5):536.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.009]
ZHA Shanhui,LIU Jie,REN Jie,et al.Clinical effect of laparoscopic surgery in treatment of elderly endometrial cancer and its influence on patients' stress,pain and postoperative recovery[J].,2023,52(2):536.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.009]
[8]冯一平,袁浩鑫,曾尚云,等.肿瘤坏死因子受体相关因子6高表达对子宫内膜癌细胞侵袭、迁移及上皮间质转化的影响[J].陕西医学杂志,2023,52(11):1598.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.032]
FENG Yiping,YUAN Haoxin,ZENG Shangyun,et al.Effects of high expression of TRAF6 on invasion,migration and epithelial-mesenchymal transition of endometrial cancer cells[J].,2023,52(2):1598.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.032]
[9]孔维娜,李 佳,赵淑华,等.代谢综合征在子宫内膜癌及其肿瘤微环境中的研究进展[J].陕西医学杂志,2023,52(11):1607.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.034]
KONG Weina,LI Jia,ZHAO Shuhua,et al.Progress of metabolic syndrome in endometrial cancer and its tumor microenvironment[J].,2023,52(2):1607.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.034]
[10]周 琴,黄丽琼,胡丽蓉,等.超声造影参数评估子宫内膜癌患者预后价值研究[J].陕西医学杂志,2024,(8):1055.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.010]
ZHOU Qin,HUANG Liqiong,HU Lirong,et al.Value of contrast-enhanced ultrasound parameters in evaluating prognosis of patients with endometrial carcinoma[J].,2024,(2):1055.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.010]